| 000 | 01740 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515121917.0 | ||
| 264 | 0 | _c20080616 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.0709981105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchug, Thaddeus T | |
| 245 | 0 | 0 |
_aOvercoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cMay 2008 |
||
| 300 |
_a7546-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aFatty Acid-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMammary Neoplasms, Animal _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPPAR delta _xagonists |
| 650 | 0 | 4 |
_aPPAR-beta _xagonists |
| 650 | 0 | 4 |
_aReceptors, Retinoic Acid _xagonists |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTretinoin _xpharmacology |
| 700 | 1 | _aBerry, Daniel C | |
| 700 | 1 | _aToshkov, Illia A | |
| 700 | 1 | _aCheng, Le | |
| 700 | 1 | _aNikitin, Alexander Yu | |
| 700 | 1 | _aNoy, Noa | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 105 _gno. 21 _gp. 7546-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.0709981105 _zAvailable from publisher's website |
| 999 |
_c17989856 _d17989856 |
||